Integrated BioPharma, Inc.

Integrated BioPharma, Inc. is primarily engaged in the business of manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. The company's customers are located primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was originally incorporated on August 31, 1995, as Chem International, Inc., changed its name to Integrated Health Technologies, Inc. on December 5, 2000, and then to Integrated BioPharma, Inc. on January 29, 2003. The company continues to operate as Chem International, Inc. with certain customers and vendors. The company's business segments include: (a) Contract Manufacturing, operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. (b) Other Business Lines, which encompasses the operations of MDC Warehousing and Distribution, Inc., a provider of warehousing and fulfillment services; Chem International, Inc. (Chem), a distributor of certain raw materials for DSM Nutritional Products LLC and the company's holding entity; and all other inactive subsidiaries. In the fiscal years ended June 30, 2026, and 2025, approximately 90% and 84%, respectively, of the company's consolidated net sales were concentrated among two customers: Life Extension Quality Supplements and Vitamins, Inc. (Life Extension) and Herbalife Nutrition LTD (Herbalife). Both customers are part of the Contract Manufacturing Segment. Life Extension and Herbalife represented approximately 68% and 25%, respectively, of the Contract Manufacturing Segment's net sales in the fiscal year ended June 30, 2026, and approximately 62% and 26%, respectively, in the fiscal year ended June 30, 2025.